Julio Cortez/Connected Press
UFC fighter Jon Jones reportedly passed a drug test issued by the United States Anti-Doping Agency on Dec. 29, the night he defeated Alexander Gustafsson at UFC 232.
Brett Okamoto of ESPN reported the guidelines, citing California Inform Athletic Fee government director Andy Foster. Jones was once furthermore examined by Foster’s agency, nevertheless all assessments that were issued that night returned dapper.
Okamoto defined there were “no picograms of the M3 metabolite, which was once the provision of the total controversy and drama last month.”
Marc Raimondi of MMA Combating equipped context for that “controversy and drama,” noting Foster allowed Jones to fight at UFC 232 due to Dr. Daniel Eichner, the director at Sports actions Remedy Be taught and Checking out Laboratory (SMRTL), said “There’ll not be any such thing as a proof that DHCMT has been re-administered.”
Eichner believed there was once no proof Jones took unique substances since he was once suspended for a certain drug test for Turinabol metabolites present in a July 2017 sample. He was once fined $205,000 and saw his license revoked for that violation.
Foster licensed Eichner’s conclusion the low levels of M3 metabolite stumbled on in Jones’ assessments were “most seemingly” from “residual levels from a outdated publicity.”
On the other hand, he required Jones to pass a steroid test—which he did—and enroll with the Voluntary Anti-Doping Agency (VADA) earlier than he fought in UFC 232.
The match with Gustafsson was once gentle moved to Inglewood, California, for the reason that Nevada Inform Athletic Fee wouldn’t grant Jones a license to fight in Las Vegas following the irregular drug test.
That didn’t end him from handling his opponent with relative ease, notching a victory by capacity of 1/Three-round TKO to accelerate to 23-1 with sixteen wins by stoppage and attend the UFC gentle heavyweight title.